-+ 0.00%
-+ 0.00%
-+ 0.00%

*Albemarle: On Track to Achieve Full-Yr Run-Rate Cost and Productivity Improvements of Approximately $450M, Surpassing Initial $300M to $400M Target >ALB

Dow Jones·11/05/2025 21:19:00

Please log in to view news